Prevalence, severity, and associated factors of depression in newly diagnosed people living with HIV in Kilimanjaro, Tanzania: a cross-sectional study.
Depression
Determinants of health
HIV
Mental health
Newly diagnosed
Patient Health Questionnaire
Sub-saharan Africa
Tanzania
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
01 02 2023
01 02 2023
Historique:
received:
20
07
2022
accepted:
23
12
2022
entrez:
2
2
2023
pubmed:
3
2
2023
medline:
4
2
2023
Statut:
epublish
Résumé
Depression is particularly common among people living with Human Immunodeficiency Virus (HIV), with some studies showing a prevalence of depression three times higher among people living with HIV as compared to the general public. The stress associated with being diagnosed with HIV can be quite impactful, including concerns about one's long-term health, stigma, and the burden of long-term treatment. Therefore, it is common for a new HIV diagnosis to contribute to the onset of depressive symptoms. The objective of this study was to determine the prevalence and severity of depression, and its associated factors in people diagnosed with HIV within the past 12 months. We conducted a cross-sectional survey with patients newly diagnosed with HIV at three hospitals in the Kilimanjaro region of Tanzania utilizing a locally validated version of the Patient Health Questionnaire-9 (PHQ-9) as a screener for depression, the Demographic Health Survey (SES-DHS8) for socio-demographic characteristics, and the Duke-UNC Functional Social Support Questionnaire (FSSQ) to assess perceived social support. We enrolled 272 participants between September and December 2020, diagnosed with HIV within the past 12 months. Analysis of Co-variance (ANCOVA) and Bonferroni post-hoc analysis were used to determine associations of sociodemographic variables with the dependent variable of depression. Overall prevalence of depression in our sample was 41%, including 54 participants (20%) with moderate symptoms, 42 (15%) with moderately severe symptoms, and 16 (6%) with severe symptoms. Severity was highest in participants diagnosed with HIV less than 1 month ago. An ANCOVA model (overall F = 4.72, p < 0.001) assessing factors associated with greater depression severity revealed significant effects of study site (F = 7.6, p < 0.001), female gender (F = 5.11, p = 0.02), and less time since HIV diagnosis (F = 12.3, p < 0.001). The study demonstrates very high prevalence of depression among people living with HIV in this setting, particularly among those newly diagnosed, female participants, and those seen at the larger regional referral hospital. Integration of mental health screening and interventions into CTC care is vital in the first visits following a positive test result and may be tailored to meet the needs of patients at highest risk for developing symptoms of depression.
Sections du résumé
BACKGROUND
Depression is particularly common among people living with Human Immunodeficiency Virus (HIV), with some studies showing a prevalence of depression three times higher among people living with HIV as compared to the general public. The stress associated with being diagnosed with HIV can be quite impactful, including concerns about one's long-term health, stigma, and the burden of long-term treatment. Therefore, it is common for a new HIV diagnosis to contribute to the onset of depressive symptoms. The objective of this study was to determine the prevalence and severity of depression, and its associated factors in people diagnosed with HIV within the past 12 months.
METHODS
We conducted a cross-sectional survey with patients newly diagnosed with HIV at three hospitals in the Kilimanjaro region of Tanzania utilizing a locally validated version of the Patient Health Questionnaire-9 (PHQ-9) as a screener for depression, the Demographic Health Survey (SES-DHS8) for socio-demographic characteristics, and the Duke-UNC Functional Social Support Questionnaire (FSSQ) to assess perceived social support. We enrolled 272 participants between September and December 2020, diagnosed with HIV within the past 12 months. Analysis of Co-variance (ANCOVA) and Bonferroni post-hoc analysis were used to determine associations of sociodemographic variables with the dependent variable of depression.
RESULTS
Overall prevalence of depression in our sample was 41%, including 54 participants (20%) with moderate symptoms, 42 (15%) with moderately severe symptoms, and 16 (6%) with severe symptoms. Severity was highest in participants diagnosed with HIV less than 1 month ago. An ANCOVA model (overall F = 4.72, p < 0.001) assessing factors associated with greater depression severity revealed significant effects of study site (F = 7.6, p < 0.001), female gender (F = 5.11, p = 0.02), and less time since HIV diagnosis (F = 12.3, p < 0.001).
CONCLUSION
The study demonstrates very high prevalence of depression among people living with HIV in this setting, particularly among those newly diagnosed, female participants, and those seen at the larger regional referral hospital. Integration of mental health screening and interventions into CTC care is vital in the first visits following a positive test result and may be tailored to meet the needs of patients at highest risk for developing symptoms of depression.
Identifiants
pubmed: 36726113
doi: 10.1186/s12888-022-04496-9
pii: 10.1186/s12888-022-04496-9
pmc: PMC9890688
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
83Subventions
Organisme : FIC NIH HHS
ID : D43 TW009595
Pays : United States
Informations de copyright
© 2023. The Author(s).
Références
J Family Med Prim Care. 2017 Jul-Sep;6(3):549-553
pubmed: 29417006
World J Psychiatry. 2016 Mar 22;6(1):128-35
pubmed: 27014603
AIDS. 2020 Sep 1;34(11):1657-1664
pubmed: 32701584
J Int Assoc Physicians AIDS Care (Chic). 2010 Jul-Aug;9(4):218-26
pubmed: 20798401
BMC Psychiatry. 2018 Aug 16;18(1):259
pubmed: 30115040
PLoS One. 2015 Oct 15;10(10):e0140001
pubmed: 26469186
Afr J Psychiatry (Johannesbg). 2010 Mar;13(1):43-51
pubmed: 20428598
Braz J Infect Dis. 2017 Sep - Oct;21(5):507-514
pubmed: 28535397
AIDS Behav. 2021 Apr;25(4):1171-1184
pubmed: 33180253
J Gen Intern Med. 2003 Jun;18(6):450-60
pubmed: 12823652
PLoS One. 2014 May 05;9(5):e95469
pubmed: 24798428
Int J Psychiatry Med. 2008;38(1):43-51
pubmed: 18624016
Eval Program Plann. 2018 Jun;68:148-156
pubmed: 29597104
PLoS One. 2019 Oct 31;14(10):e0224515
pubmed: 31671160
PLoS One. 2021 Apr 22;16(4):e0250074
pubmed: 33886619
AIDS. 2017 Jan 14;31(2):263-271
pubmed: 27835614
Clin Infect Dis. 2007 Dec 1;45(11):1492-8
pubmed: 17990233
J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):470-7
pubmed: 17179766
PLoS One. 2012;7(11):e48671
pubmed: 23209556
AIDS Behav. 2006 Jul;10(4 Suppl):S105-11
pubmed: 16802195
AIDS Care. 2021 Oct 26;:1-8
pubmed: 34702095
Int J Psychiatry Med. 2006;36(3):367-81
pubmed: 17236703
J Psychiatry Neurosci. 2015 Jul;40(4):219-21
pubmed: 26107348
Soc Psychiatry Psychiatr Epidemiol. 2013 Oct;48(10):1675-85
pubmed: 23229203
Afr J AIDS Res. 2011 Sep;10(3):247-54
pubmed: 25859793
Indian J Psychol Med. 2013 Apr;35(2):121-6
pubmed: 24049221
AIDS Care. 2015;27(8):979-85
pubmed: 25741909
AIDS Behav. 2021 Jan;25(1):104-112
pubmed: 32572712
PLoS One. 2010 Dec 08;5(12):e14252
pubmed: 21170384
J Clin Diagn Res. 2014 Oct;8(10):WC01-4
pubmed: 25478433
AIDS Behav. 2011 Aug;15(6):1161-70
pubmed: 20711651
AIDS Care. 2017 Mar;29(3):280-284
pubmed: 27866410
Glob Ment Health (Camb). 2018 Nov 19;5:e38
pubmed: 30637111
J Int Assoc Provid AIDS Care. 2021 Jan-Dec;20:2325958220985665
pubmed: 33472517
Rev Soc Bras Med Trop. 2015 Jul-Aug;48(4):390-8
pubmed: 26312927
Med Care. 1988 Jul;26(7):709-23
pubmed: 3393031
BMC Psychiatry. 2013 Sep 22;13:228
pubmed: 24053612
Prev Sci. 2014 Jun;15(3):318-28
pubmed: 23868419
BMC Psychiatry. 2020 Sep 24;20(1):462
pubmed: 32972394
J Assoc Nurses AIDS Care. 2021 Nov-Dec 01;32(6):682-692
pubmed: 33908407
J Int AIDS Soc. 2019 Aug;22(8):e25332
pubmed: 31424617
Neurol Psychiatry Brain Res. 2019 Feb;31:9-14
pubmed: 32863596
PLoS One. 2017 Aug 4;12(8):e0181960
pubmed: 28783739
AIDS Behav. 2017 Jun;21(6):1632-1640
pubmed: 27251436
AIDS Patient Care STDS. 2021 Aug;35(8):308-317
pubmed: 34375138
PLoS One. 2019 Oct 23;14(10):e0224322
pubmed: 31644606
AIDS Behav. 2018 May;22(5):1639-1651
pubmed: 29081046
Clin Pract Epidemiol Ment Health. 2020 Jul 21;16:59-66
pubmed: 32742296
Glob Ment Health (Camb). 2021 Aug 26;8:e31
pubmed: 34513000